Supriya Lifescience Limited (NSE:SUPRIYA)
India · Delayed Price · Currency is INR 561.90
-25.65 (-4.37%)
Mar 30, 2026, 3:30 PM IST
Supriya Lifescience Market Cap
Supriya Lifescience has a market cap or net worth of 45.22 billion as of March 31, 2026. Its market cap has decreased by -12.75% in one year.
Market Cap
45.22B
Enterprise Value
44.24B
Revenue
7.35B
Ranking
n/a
PE Ratio
24.39
Stock Price
561.90
Market Cap Chart
Since December 28, 2021, Supriya Lifescience's market cap has increased from 31.46B to 45.22B, an increase of 43.76%. That is a compound annual growth rate of 8.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 45.22B | -25.23% |
| Dec 31, 2025 | 60.48B | 1.58% |
| Dec 31, 2024 | 59.54B | 135.04% |
| Dec 29, 2023 | 25.33B | 33.91% |
| Dec 30, 2022 | 18.92B | -51.41% |
| Dec 31, 2021 | 38.93B | 23.76% |
| Dec 28, 2021 | 31.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 598.96B |
| Anthem Biosciences | 382.71B |
| OneSource Specialty Pharma | 165.87B |
| Concord Biotech | 106.16B |
| Blue Jet Healthcare | 59.64B |
| Zota Health Care | 35.82B |
| Dishman Carbogen Amcis | 22.37B |
| Panacea Biotec | 19.59B |